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Chromosomal abnormalities, such as unbalanced translocations and copy number variants (CNVs), are found in autism spectrum disorders (ASDs) [Sanders et al. (2011) Neuron 70: 863-885] . Many chromosomal abnormalities, including sub microscopic genomic deletions and duplications, are missed by G-banded karyotyping or Fragile X screening alone and are picked up by chromosomal microarrays [Shen et al. (2010) Pediatrics 125: e727-735] . Translocations involving chromosomes 4 and 8 are possibly the second most frequent translocation in humans and are often undetected in routine cytogenetics [Giglio et al. (2002) Circulation 102: 432-437].
Deletions of 4p16 have been associated with Wolf-Hirschhorn syndrome while 4p16 duplications have been associated with an overgrowth syndrome and mild to moderate mental retardation [Partington et al. (1997) Journal of Medical Genetics 34: 719-728]. The 8p23.3 region contains the autism candidate gene DLGAP2, which can contribute to autism when disrupted [Marshall et al. (2008) The American Journal of Human Genetics 82: [477] [478] [479] [480] [481] [482] [483] [484] [485] [486] [487] [488] . There has been a case report of a family with autism spectrum disorder (ASD), prominent obsessional behavior, and overgrowth in patients with der (8) t (4;8) p (16;23) [Partington et al. (1997) ]. This is an independent report of a male patient with autism, obsessive compulsive disorder (OCD), attention-deficit hyperactivity disorder (ADHD), and an overgrowth syndrome, whose de novo unbalanced translocation der (8) t (4;8) p (16.1→ter; 23.1→ter) was initially missed by routine cytogenetics but detected with SNP microarray, allowing higher resolution of translocation breakpoints.
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The autism spectrum disorders (ASDs) are a group of neurodevelopmental disorders characterized by persistent impairment in reciprocal social communication and social interaction as well as the presence of restricted, repetitive patterns of behavior, interests, or activities; these symptoms are present from early childhood and limit or impair everyday functioning (American Psychiatric Association, 2013) . Autism is known to be strongly heritable (Bailey et al., 1995; Klei et al., 2012; Stilp, Gernsbacher, Schweigert, Arneson, & Goldsmith, 2010 ) with environmental influences (Hallmayer et al., 2011) . Mode of inheritance can play a significant role in the genetic acquisition of autism as evidenced by imprinting of 15q11-q13leading to autism or atypical autism when maternally inherited but not when paternally inherited (Cook et al., 1997) . Pinto et al. (2010) found that many autism cases carried a higher global burden of rare (less than 1%) genic copy number variants (CNVs) when compared to controls, adding to the body of evidence that multiple rare CNVs contribute to vulnerability to ASDs (Cook & Scherer, 2008; Pinto et al., 2014) .
We describe here a patient with autism, obsessive compulsive disorder (OCD), attention deficit hyperactivity disorder (ADHD), and an overgrowth syndrome, who had an unbalanced translocation der (8) t (4;8) (p16.1→pter; p23.1→pter) identified during a larger Autism Genome Project SNP microarray CNV study (Pinto et al., 2014) , which was here confirmed to be de novo by FISH and microsatellite studies.
| CLINICAL REPORT
The patient was born at term to nonconsanguineous healthy parents after a pregnancy complicated by preterm labor treated with cervical cerclage, bedrest from month five and terbutaline. He was noted in the perinatal period to be very irritable. Birth weight was 2.55 kg (5th centile), birth length was 50.8 cm (50th centile) (Hall, Allanson, Gripp, & Slavotinek, 2006) .
He was initially diagnosed with ADHD and learning disability, enrolled in early childhood services, and received speech, language, and occupational therapy at the age of 3 years. At 5 years of age he was placed in a special education school; he was seen by neurology and he was diagnosed with autism by a psychiatrist.
At age 12 years he was enrolled in an escitalopram pharmacogenetic study at the University of Chicago according to a protocol approved by the University of Chicago IRB and subsequently the University of Illinois at Chicago IRB (Owley et al., 2010) . He was clinically diagnosed with autism; the Autism Diagnostic Observation Schedule (ADOS) (Lord, Rutter, DiLavore, & Risi, 2002) and the Autism Diagnostic Interview−Revised (ADI-R) (Rutter, Le Couteur, & Lord, 2002) were administered with a classification of autism. The Raven's Coloured Progressive Matrices (RCPM) (Raven, 1993) was administered to measure nonverbal intelligence (standard score 33) and the Peabody Picture Vocabulary Test, Third Edition (PPVT-III) (Dunn & Dunn, 1997 ) was administered to assess receptive language; he achieved an age equivalent (AE) of 4 years, 3 months.
During the course of the trial, he was unable to tolerate an upward titration of escitalopram beyond the starting dose of 2.5 mg each day.
He had an improvement in Aberrant Behavior Checklist−Community, Irritability subscale (ABC-IRR) (Aman, Burrow, & Wolford, 1995; Aman, Singh, Stewart, & Field, 1985) from a baseline score of 12 to a score of 4 after one week of being on 2.5 mg each day of escitalopram. Titration up to 5 mg each day on week two of the study led to an exacerbation to an ABC-IRR of 22 so his dose was reduced to 2.5 mg each day. At the conclusion of the trial at week 11, his ABC-IRR score was 1.
At age 18, he returned to the University of Illinois at Chicago to participate in The Autism Simplex Collection (TASC). Adaptive skills were evaluated by the Vineland Adaptive Behavior Scales, Second Edition (VABS II) (Sparrow, Cicchetti, & Balla, 2005) (Constantino et al., 2004 ) was administered and his T-Score was 86, in the severe range. His ABC-IRR score was 5.
His OCD symptoms consisted of excessive hand washing, excessive use of toilet paper, paper towels, and other repetitive behaviors. Our patient also suffered from poor sleep, irritability, and aggression−symptoms related to his OCD and related anxiety. Clonidine helped with sleep, Adderall helped with hyperactivity, inattention, and irritability. However, treating the anxiety and OCD and adjusting the SSRI dose remained a challenge.
When he was 22 years-old, medications were adjusted to target OCD and skin picking. Escitalopram was increased from 5 to 10 mg;
Adderall was decreased from a total of 40 to 20 mg in divided doses, and risperidone was added. Between the age of 22 and 25 his Adderall and risperidone doses remained unchanged. His anxiety improved with gradual increases to his escitalopram dose from 10 to 20 mg a day. He was better able to use sentences to communicate and he was more comfortable making brief eye contact when encouraged. His skin healed, indicating a decrease in skin picking.
His other OCD-related behaviors also improved and he was more receptive to attending an adult program regularly on this medication regimen.
Additional past medical history included a ventricular septal defect that closed spontaneously in infancy. He had eczema as a child and psoriasis as an adult. He had headaches treated effectively with an over-the-counter preparation. He was otherwise healthy with no hospital admissions and no history of surgery. Family history revealed that his 7 years older sister and 18 months older brother developed typically. There was no family history of OCD or pervasive developmental disorder, although his mother reported that father's family had difficulty with socialization.
| Physical Examination at 21 Years Old
On examination, he was macrocephalic (head circumference 60 cm, 1.5 cm greater than the 98th centile). Weight was 102.5 kg (1.5 kg greater than the 97th centile) and height was 183 cm (81st centile) with a body mass index of 30.6 (95th centile) (Hall et al., 2006) . His head was scaphocephalic, and he had hypertrichosis of the eyelashes. He had an extra fold in the cartilage at the superior aspect of each pinna, and had a prominent lower lip. His left upper canine tooth was congenitally absent, and his mother reported that his dentist noted a duplicate set of wisdom teeth in his lower jaw. He had a mild thoracic scoliosis concave to the right, and two lacy hyperpigmented macules: 6 × 1.5 cm on the left flank, and 5 × 2 cm on the right elbow. He had mild global hypotonia and preferred to walk on his toes, but did not have Achilles tendon contractures, muscle weakness or spasticity. Cranial nerve, coordination and sensory examinations were normal.
Additional measurements were obtained when he was 26 yearsold. See Supplementary Information (Table SI) 
| Microarray Analysis and CNV Validation
Earlier fragile X testing and initial routine Giemsa-banded (G-banded) karyotyping for the patient were negative before presentation to our clinic. As part of the IRB approved TASC study (Buxbaum et al., 2014) , DNA was extracted from whole-blood for the patient and both parents, hybridized to the Illumina 1M duo DNA Beadchip array (Illumina Inc., San Diego, CA), and analyzed for CNV as previously described. Validation of the ∼9 Mb-4p16.3 duplication and ∼7 Mb8p21.3 deletion was performed with SYBR Green I-based real-time (RT) quantitative PCR (qPCR) using the standard curve method (Pinto et al., 2010) .
| MATERIALS AND METHODS

| Sequential G-to-FISH
Freshly drawn blood from patient, both parents, and unaffected male older sibling was obtained for subsequent FISH and microsatellite analyses. Metaphase slides were obtained from peripheral blood lymphocytes and conventional G-banded karyotype was performed for all samples. No 4p/8p abnormalities were apparent in parents or sibling. Three-color FISH was performed using standard procedures with RP11 clones. Probe and slide preparation as well as DNA hybridization followed conventional methods (Joseph-George et al., 2011) . FISH analysis was conducted on both metaphase and interphase chromosomes.
| Microsatellite Testing
The DNA from the case subject and all family members was extracted from blood in EDTA using standard methods. Paternity testing used the AmpFlSTR® Identifiler® PCR Amplification Kit. Informative array SNP and microsatellite marker analyses were conducted to determine the chromosome origin for the 8p16.3-pter deletion and 4p16.3-pter duplication.
| GENETIC RESULTS
A relatively large (∼6,839,842 bp) deletion of 8p and a duplication of ∼8,962,937 bp of 4p were found from the CNV analysis previously reported in a table in Pinto et al. (2014) . 8p23.2 was deleted from the p telomere to hg18 chr:6994825 8p(23.1 →ter). 4p16.1 was duplicated from the 4p telomere to chr4:9016339 or 4p(16.1 → ter).
FISH confirmed our patient's de novo der (8) t (4;8) (p16.1 → pter; p23.1 → pter) unbalanced translocation (Figure 1) . Informative PCR markers demonstrated that both the de novo 8p deletion and 4p duplication occurred on the maternal chromosome (Figures 2 and 3) .
He did not show mosaicism−at least 100 interphase nuclei and 21 metaphases were inspected, and all of his cells showed the unbalanced t(4;8).
| DISCUSSION
A patient with autism, OCD, ADHD, and an overgrowth syndrome was found to have a de novo unbalanced translocation with a 4p duplication and an 8p deletion: der (8) t (4;8) (Giglio et al., 2002; Partington et al., 1997; Tranebjaerg, Petersen, Hove, Rehder, & Mikkelsen, 1984) . FGFR3 was likely present in three copies and caused him to present clinically with large hands and feet. Cyr and colleagues reported on a 4p16.3 microduplication involving FGFR3 in a male who was last seen at age 2 years; overgrowth was not reported and this may be because the patient was too young to exhibit this feature of three copies of FGFR3 (Cyr et al., 2011) . It is possible that our patient's 4p16.2 duplication contributed to his autism; this region is large enough that other genes may contribute but Partington reported other translocations that did not involve 8p and did not report ASD, so 4p duplications in that series were associated with overgrowth but not reported ASD. In summary, although exclusion of other causes of overgrowth was not performed, overgrowth has been a consistent finding in 4p partial trisomy.
Recently, Skrlec and colleagues described a 5 month-old patient who had been referred to genetics because of dysmorphic features including a narrow forehead, hirsutism, wide nasal bridge, anteverted nostrils, low set and malformed ears, small mandible, and low hairline on the neck; he also had an atrio-ventricular septal defect (Skrlec et al., 2014) . His de novo translocation was determined using G-banding and Der (8) t (4;8) (p16;p23) has been considered to possibly be the second most frequent translocation after t(11q;22q) in humans; many of these translocations may not be detected by routine cytogenetics (Giglio et al., 2002) . However, there have been few reports of der (8) t (4;8) p(16;23) providing details including behavioral phenotype. 8p23 deletions have been associated with mild mental retardation, cardiac abnormalities, microcephaly, and autism (Giglio et al., 2000; Hutchinson, Wilson, & Voullaire, 1992; Tranebjaerg et al., 1984) .
A duplication at 8p23.2 that intersected and likely disrupted DLGAP2 has been associated with a male with ASD, repetitive behaviors, and moderate receptive/expressive language delay−discussed by both Marshall in 2008 and, after analysis on a higher-resolution array, reported by Pinto and colleagues (Marshall et al., 2008; Pinto et al., 2010) . The DLGAP family of proteins interacts with SHANK scaffolding proteins, which are involved in the assembly and stability of synapses (Romorini et al., 2004) . Some SHANK proteins are organizers of post synaptic density (Romorini et al., 2004) . Because disruptions of SHANK3 and of DLGAP2 have been associated with ASD (Durand et al., 2007; Gau et al., 2010) , it is possible that a deletion of DLGAP2 contributed to our patient's autism (Pinto et al., 2010; Romorini et al., 2004) . It is also of note that Dlgap3 (Sapap3) knockout mice have prominent compulsive behavior (Welch et al., 2007) and that rare variants of DLGAP3 have been identified in patients with OCD (Zuchner et al., 2009 ). 4p and 8p deletions are not easily detected in routine cytogenetics, and many authors mention how they were missed initially (Giglio et al., 2002; Partington et al., 1997; Tranebjaerg et al., 1984) . This was true with our patient as well, whose translocation was eventually detected by CMA. This further supports the argument that CMA should be used in the diagnostic testing of patients with ASD (Shen et al., 2010 ).
In conclusion, we report the detailed phenotype of the second case of der (8) t (4;8) p (16;23) with ASD and prominent OCD.
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